- ISBN: 9783527338603 | 3527338608
- Cover: Hardcover
- Copyright: 4/10/2017
Unique in combining the expertise of practitioners from university hospitals and that of academic researchers, this timely monograph presents selected topics catering specifically to the needs and interests of natural scientists and engineers as well as physicians who are concerned with developing nanotechnology-based treatments to improve human health.
To this end, the book cover the materials aspects of nanomedicine, such as the hierarchical structure of biological materials, the imaging of hard and soft tissues and, in particular, concrete examples of nanotechnology-based approaches in modern medical treatments. The whole is rounded off by a discussion of the opportunities and risks of using nanotechnology and nanomaterials in medicine, backed by case studies taken from real life.
Bert Muller is Professor for Materials Science in Medicine at the University of Basel and teaches physics at ETH Zurich. He received a diploma in mechanical engineering, followed by M.Sc. degrees in Physics and English from the Dresden University of Technology, and obtained a PhD in experimental physics from the University of Hannover, Germany. For his achievements he was granted with the Morton M. Traum Award of the American Vacuum Society. Afterwards, he worked as researcher at the Paderborn University, Germany, as Feodor Lynen Fellow and research associate at the EPF Lausanne and as team leader at ETH Zurich. He has become a faculty member of the Physics Department at ETH Zurich. Ten years ago he has founded the Biomaterials Science Center. Currently, this center has more than twenty researchers dealing with nanotechnology-based artificial muscles for incontinence treatment, smart nano-containers to treat cardiovascular diseases, high-resolution X-ray imaging to visualize the human body down to the molecular level, computational sciences of tissues in health and disease and other applications of physics and nanosciences in medicine and dentistry. He is Fellow of SPIE and an active member of the European Academy of Sciences and Arts.
Marcel Van de Voorde has 40 years` experience in European Research Organisations including CERN-Geneva, European Commission, with 10 years at the Max Planck Institute in Stuttgart, Germany. For many years, he was involved in research and research strategies, policy and management, especially in European research institutions. He holds a Professorship at the University of Technology in Delft, the Netherlands, as well as multiple visiting professorships in Europe and worldwide. He holds a doctor honoris causa and various honorary Professorships.
He is senator of the European Academy for Sciences and Arts, in Salzburg and Fellow of the World Academy for Sciences. He is a Fellow of various scientific societies and has been decorated by the Belgian King. He has authored of multiple scientific and technical publications and co-edited multiple books in the field of nanoscience and nanotechnology.
Marcel Van de Voorde has 40 years` experience in European Research Organisations including CERN-Geneva, European Commission, with 10 years at the Max Planck Institute in Stuttgart, Germany. For many years, he was involved in research and research strategies, policy and management, especially in European research institutions. He holds a Professorship at the University of Technology in Delft, the Netherlands, as well as multiple visiting professorships in Europe and worldwide. He holds a doctor honoris causa and various honorary Professorships.
He is senator of the European Academy for Sciences and Arts, in Salzburg and Fellow of the World Academy for Sciences. He is a Fellow of various scientific societies and has been decorated by the Belgian King. He has authored of multiple scientific and technical publications and co-edited multiple books in the field of nanoscience and nanotechnology.
Nanomedicine: Present Accomplishments and Far-Reaching Promises XXI
Part One Introduction to Nanoscience in Medicine of the Twenty-First Century 1
1 Challenges and Opportunities of Nanotechnology for Human Health 3
Bert Müller
References 6
2 Nanoscience and Nanotechnology and the Armory for the Twenty-First Century Health Care 9
Marcel Van de Voorde and Pankaj Vadgama
2.1 Conceptual Dream 9
2.2 A Real World Encounter 9
2.3 Mapping the Microcosm of Disease 10
2.4 Delivery at the Clinical “Coal Face” 10
2.5 A High Precision Aim for Disease Targets 10
2.6 A Materials Revolution for Clinical Care 11
2.7 Robotics for Microrepair and Healing 12
2.8 A Dialog with Cells 12
2.9 Stealth Materials for a More Potent Delivery 13
2.10 Improved Biointerrogation for a Better Understanding 13
2.11 Crossing the Structure–Function Threshold 14
2.12 Living Implants for a Living Matrix 15
2.13 Taming the Nanointerface 15
2.14 Where are We Now? 16
2.15 Where will the Revolution Take Us? 16
2.16 Conclusions 17
References 18
3 Nanomedicine Activities in the United States and Worldwide 21
Carlotta Borsoi, Joy Wolfram, and Mauro Ferrari
3.1 Drug Delivery 22
3.2 Diagnostics 31
3.3 Scaffolds 33
3.4 Clinically Approved Nanoproducts 37
References 39
Part Two Leading Cause of Death: Cardiovascular Diseases 51
4 Challenges in Cardiovascular Treatments Using Nanotechnology-Based Approaches 53
Till Saxer and Margaret N. Holme
4.1 Introduction 53
4.2 Unmet Needs in Cardiology 54
4.3 Nanoparticles for Treatment of CVD 58
4.4 Nanotherapeutics in Surgical Interventions 62
4.5 Conclusions 65
References 66
5 Smart Container for Targeted Drug Delivery 71
Andreas Zumbuehl
5.1 Introduction 71
5.2 Liposomes 72
5.3 Shear Forces and Vesicles 76
5.4 Conclusions 79
References 79
6 Human Nano-Vesicles in Physiology and Pathology 83
Arun Cumpelik and Jürg A. Schifferli
6.1 Introduction 83
6.2 Nomenclature and Definition 84
6.3 Stimulus for Vesicle Release 85
6.4 Overview of Extracellular Vesicle Biology 86
6.5 NVs of Polymorphonuclear Leukocytes 88
6.6 Erythrocyte NVs 89
6.7 Platelet NVs 91
6.8 Conclusions 92
Acknowledgment 93
References 93
7 Challenges and Risks of Nanotechnology in Medicine: An Immunologist’s Point of View 97
János Szebeni
7.1 Introduction 97
7.2 The Immune Stimulatory Vicious Cycle 98
7.3 The Cause of Immune Recognition of Nanomedicines: Similarity to Viruses 100
7.4 Processes in the Immune Stimulatory Vicious Cycle 101
7.5 Particle Features Influencing the Immune Side Effects of Nanomedicines 109
7.6 Experimental Analysis of the Adverse Immune Effects of Nanomedicines 110
7.7 Decision Tree to Guide the Evaluation of the CARPAgenic Potential of Nanomedicines 113
7.8 Outlook 114
References 114
Part Three Second Most Common Cause of Death: Cancer 125
8 Challenges of Applying Targeted Nanostructures with Multifunctional Properties in Cancer Treatments 127
Jean-Luc Coll and Jungyoon Choi
8.1 Introduction 127
8.2 Enhanced Permeability and Retention Effect 128
8.3 Physicochemical Factors that Influence NP Passive Properties 129
8.4 Targeted NPs 134
8.5 Conclusions 143
Acknowledgments 144
References 145
9 Highly Conformal Radiotherapy Using Protons 157
Antony John Lomax
9.1 Introduction 157
9.2 Proton Physics 161
9.3 Delivering Proton Therapy 165
9.4 Clinical Applications 172
9.5 The Future of Proton Therapy 177
9.6 Is There a Role for Nanotechnology in Proton Therapy? 183
References 186
10 Self-Organization on a Chip: From Nanoscale Actin Assemblies to Tumor Spheroids 191
Cora-Ann Schoenenberger and Thomas Pfohl
10.1 Introduction 192
10.2 Microfluidic Cell Culture 197
10.3 Self-Regulated Loading of Cells into Microchambers 197
10.4 2D Cell Culture in Microfluidics 200
10.5 Expanding Microfluidic Cell Culture to the Third Dimension 200
10.6 Microfluidic Biomimetic Models of Cancer 204
10.7 Future Perspectives 204
Acknowledgments 205
References 205
11 The Nanomechanical Signature of Tissues in Health and Disease 209
Daphne O. Asgeirsson, Philipp Oertle, Marko Loparic, and Marija Plodinec
11.1 Summary 209
11.2 Tissue Mechanics Across Length Scales 210
11.3 Atomic Force Microscopy (AFM) in Cell and Tissue Biology 211
11.4 The Nanomechanical Signature of Articular Cartilage 218
11.5 The Nanomechanical Signature of Mammary Tissues 224
11.6 AFM – The Diagnostic and Prognostic Tool of the Future 229
Acknowledgments 232
Competing Financial Interests 232
References 232
Part Four Most Common Diseases: Caries, Musculoskeletal Diseases, Incontinence, Allergies 241
12 Revealing the Nano-Architecture of Human Hard and Soft Tissues by Spatially Resolved Hard X-Ray Scattering 243
Hans Deyhle and Bert Müller
12.1 Introduction 243
12.2 Spatially Resolved Hard X-Ray Scattering 244
12.3 Nanoanatomy of Human Hard and Soft Tissues 251
12.4 Conclusions and Outlook 259
References 259
13 Regenerative Dentistry Using Stem Cells and Nanotechnology 263
Thimios A. Mitsiadis and Giovanna Orsini
13.1 Introduction 263
13.2 Repair of Dental Tissues 264
13.3 Dental Stem Cells and Their Regenerative Potential 265
13.4 Regenerative Dentistry 267
13.5 Nanotechnology in Dentistry 269
13.6 Nanoscale Surface Modifications of Dental Biomaterials 270
13.7 Concluding Remarks 279
Acknowledgments 280
References 280
14 Nanostructured Polymers for Medical Applications 293
Prabitha Urwyler and Helmut Schift
14.1 Introduction 293
14.2 Applications of Nanostructures 295
14.3 Processes for Generation of Nanotopographies 301
14.4 Surface Patterning of Microcantilevers Using Mold Inlays 303
14.5 Surface Patterning Using Plasma Etching 306
14.6 Cell Response to Surface Patterning 308
14.7 Conclusion 309
References 310
15 Nanotechnology in the Treatment of Incontinence 315
Vanessa Leung and Christian Gingert
15.1 Urinary Incontinence 316
15.2 Fecal Incontinence 321
References 327
16 Nanomedicine in Dermatology: Nanotechnology in Prevention, Diagnosis, and Therapy 329
Kathrin Scherer Hofmeier and Christian Surber
16.1 Introduction 329
16.2 Nature of Nanoparticles 330
16.3 Absorption of Nanoparticles through Skin 333
16.4 Nanoparticles in Prevention, Diagnosis, and Therapy 336
16.5 Regulatory Issues 344
16.6 Public Perception of Nanoparticles in Topicals 344
16.7 Conclusions and Future Perspectives 345
References 347
Part Five Benefiting Patients 357
17 Therapeutic Development and the Evolution of Precision Medicine 359
Gareth D. Healey and R. Steven Conlan
17.1 Origins of Nanomedicine 359
17.2 Global Nanomedicine Market 360
17.3 Nanomedicine Cabinet 361
17.4 Application of Nanomedicine – A Paradigm Shift 365
17.5 Targeted Drug Discovery and the Human Kinome 367
17.6 Translation from Discovery to the Clinic 369
17.7 Evolution of Kinase Inhibitors 370
17.8 Nanoparticle Delivery 372
17.9 Conclusions 374
References 374
18 Benefit from Nanoscience and Nanotechnology: Benefitting Patients 379
Bert Müller and Marcel H. Van de Voorde
Index 383
What is included with this book?
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Please wait while the item is added to your bag...
